89 Zirconium-labelled girentuximab ( 89 Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma.
Mohammed Al-ZubaidiPravin ViswambaramSteve McCombieElizabeth LiowNat LenzoTom FergusonAndrew D RedfernRichard GauciDickon HaynePublished in: BMJ open (2022)
ACTRN12621000411842, NCT05046665.